Related Experiment Video
Updated: Aug 10, 2026

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
[Neurotensin, dopamine and mode of action of neuroleptics]
1INSERM U.114, Chaire de Neuropharmacologie, Collège de France, Paris.
Abstract:
It has new been almost ten years since interactions between the neurotensinergic and dopaminergic neuronal systems were first described. These results have now been confirmed on anatomical and biochemical as well as on behavioural grounds. First, we describe experiments showing that ascending dopaminergic pathways control the density of neurotensinergic binding sites in structures such as prefrontal cortex, nucleus accumbens and striatum. Secondly, we attempt to elucidate the consequences that such receptor hetero-regulations, together with the presence of mixed neurotensin/dopamine fibers in the prefrontal cortex, might have on the mode of action of neuroleptic drugs. Indeed, by blocking dopamine receptors, neuroleptics might bring about long-term and heterogeneous changes in the transmission of non dopaminergic systems in those projection areas possessing dopamine receptors. The new functional hierarchies thus produced between dopamine innervated structures might then explain the therapeutic action of neuroleptics.
Related Concept Videos
Excitatory and Inhibitory Effects of Neurotransmitters
Neurochemical Transmission: Sites of Drug Action
Drugs Affecting Neurotransmitter Synthesis
Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

